Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
Condition(s):Locally Advanced Rectal Carcinoma; Stage II Rectal Cancer AJCC v8; Stage III Rectal Cancer AJCC v8Last Updated:February 20, 2024Recruiting